483
Qilu Pharmaceutical Co., Ltd.FDA 483 - Qilu Pharmaceutical Co., Ltd. - February 22, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Qilu Pharmaceutical Co., Ltd., an Active Pharmaceutical Ingredients manufacturer in Licheng, Jinan, Shandong, China, revealed significant deficiencies in their quality system. The firm failed to adequately investigate non-conformances and performed temperature mapping studies inadequately. These issues raise concerns about the quality and integrity of APIs distributed in the US.
Open in Dashboard
ID · b0e69ff8-9c21-4a99-8e64-a297561597b1